Reboxetine and Citalopram as an Adjunct Treatment to Second Generation Antipsychotics in the Treatment of Negative Symptoms of Schizophrenia
Clinical trial NCT01300364 · UNKNOWN
Trial details
- NCT number
- NCT01300364
- Sponsor
- Fundació Sant Joan de Déu
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-01
- Primary completion
- 2011-12-01
- Enrollment
- 249
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.